Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Specimen Handling 200 Magnetic Resonance Spectroscopy 160 pembrolizumab 153 Carboplatin 117 Biopsy 108 Cyclophosphamide 100 Cisplatin 91 Paclitaxel 78 Gemcitabine 67 Bevacizumab 66 Nivolumab 59 fludarabine 57 Radiotherapy 54 Fluorouracil 52 Dexamethasone 47 Capecitabine 46 Oxaliplatin 45 Doxorubicin 44 Docetaxel 44 Pemetrexed 43 Rituximab 42 Leucovorin 42 venetoclax 40 durvalumab 38 atezolizumab 36 Radiation 36 Standard of Care 34 Prednisone 33 Injections 32 Cetuximab 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × famitinib × 30 days × Clear all

NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡